| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.31 | 0.03 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |